BIO.B
Bio-Rad Laboratories B·NYSE
--
--(--)
--
--(--)
9.05 / 10
Outperform
The company exhibits robust fundamental quality, scoring 9.1 out of 10. Key strengths include healthy net profit margin (2.11%) and strong EBIT and net profit ratios relative to revenue. However, challenges persist in year-over-year revenue growth (-47.4%) and asset-to-market value dispersion. These factors collectively support an 'Outperform' fundamental stance despite mixed signals.
Analysis Checks(8/10)
Revenue-MV
Value-0.23
Score2/3
Weight25.27%
1M Return3.00%
Value-0.23
Score2/3
Weight25.27%
1M Return3.00%
Total operating revenue (YoY growth rate %)
Value-0.47
Score1/3
Weight-15.83%
1M Return-2.56%
Value-0.47
Score1/3
Weight-15.83%
1M Return-2.56%
Net income-Revenue
Value-0.17
Score3/3
Weight58.83%
1M Return5.60%
Value-0.17
Score3/3
Weight58.83%
1M Return5.60%
Current assets turnover ratio
Value0.64
Score2/3
Weight2.03%
1M Return0.26%
Value0.64
Score2/3
Weight2.03%
1M Return0.26%
Asset-MV
Value-0.50
Score0/3
Weight-15.18%
1M Return-6.43%
Value-0.50
Score0/3
Weight-15.18%
1M Return-6.43%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight-11.55%
1M Return-1.63%
Value100.00
Score2/3
Weight-11.55%
1M Return-1.63%
Net cash flow from operating activities / Operating revenue (%)
Value19.43
Score3/3
Weight13.79%
1M Return1.58%
Value19.43
Score3/3
Weight13.79%
1M Return1.58%
Net profit margin (%)
Value2.11
Score3/3
Weight13.21%
1M Return1.57%
Value2.11
Score3/3
Weight13.21%
1M Return1.57%
EBIT / Total operating revenue (%)
Value5.46
Score3/3
Weight16.22%
1M Return1.88%
Value5.46
Score3/3
Weight16.22%
1M Return1.88%
Net profit / Total operating revenue (%)
Value2.11
Score3/3
Weight13.21%
1M Return1.57%
Value2.11
Score3/3
Weight13.21%
1M Return1.57%
Revenue-MV
Value-0.23
Score2/3
Weight25.27%
1M Return3.00%
Value-0.23
Score2/3
Weight25.27%
1M Return3.00%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight-11.55%
1M Return-1.63%
Value100.00
Score2/3
Weight-11.55%
1M Return-1.63%
Total operating revenue (YoY growth rate %)
Value-0.47
Score1/3
Weight-15.83%
1M Return-2.56%
Value-0.47
Score1/3
Weight-15.83%
1M Return-2.56%
Net cash flow from operating activities / Operating revenue (%)
Value19.43
Score3/3
Weight13.79%
1M Return1.58%
Value19.43
Score3/3
Weight13.79%
1M Return1.58%
Net income-Revenue
Value-0.17
Score3/3
Weight58.83%
1M Return5.60%
Value-0.17
Score3/3
Weight58.83%
1M Return5.60%
Net profit margin (%)
Value2.11
Score3/3
Weight13.21%
1M Return1.57%
Value2.11
Score3/3
Weight13.21%
1M Return1.57%
Current assets turnover ratio
Value0.64
Score2/3
Weight2.03%
1M Return0.26%
Value0.64
Score2/3
Weight2.03%
1M Return0.26%
EBIT / Total operating revenue (%)
Value5.46
Score3/3
Weight16.22%
1M Return1.88%
Value5.46
Score3/3
Weight16.22%
1M Return1.88%
Asset-MV
Value-0.50
Score0/3
Weight-15.18%
1M Return-6.43%
Value-0.50
Score0/3
Weight-15.18%
1M Return-6.43%
Net profit / Total operating revenue (%)
Value2.11
Score3/3
Weight13.21%
1M Return1.57%
Value2.11
Score3/3
Weight13.21%
1M Return1.57%
Is BIO.B undervalued or overvalued?
- BIO.B scores 9.05/10 on fundamentals and holds a Discounted valuation at present. Backed by its 0.60% ROE, -26.43% net margin, -11.78 P/E ratio, 1.18 P/B ratio, and 14.49% earnings growth, these metrics solidify its Outperform investment rating.
